cyclosporine has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, L; Choi, P; D'Rozario, J; Patel, R | 1 |
| Hartung, HP; Kieseier, BC | 1 |
1 review(s) available for cyclosporine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Current disease-modifying therapies in multiple sclerosis.
Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange | 2003 |
1 other study(ies) available for cyclosporine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so 'pure'.
Topics: Adrenal Cortex Hormones; Adult; Alemtuzumab; Antineoplastic Agents, Immunological; Cyclosporine; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Multiple Sclerosis, Relapsing-Remitting; Mycophenolic Acid; Neutropenia; Purpura, Thrombocytopenic, Idiopathic; Red-Cell Aplasia, Pure; Rituximab; Treatment Outcome; Vincristine | 2022 |